Notice of Intent to Sole Source – Miltenyi Biotec, Inc

The National Institutes of Health (NIH) is issuing a notice of intent to sole source a Miltenyi Biotec GentleMACS Octo Dissociator with Heater. This equipment is essential for the automated dissociation and homogenization of preclinical and clinical tissue samples prior to liquid chromatography-mass spectrometry (LC-MS) analysis. The instrument will be located in the Clinical Pharmacology Laboratory (CPL) at the NIH. The acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures. • The equipment is required for pharmacokinetic (PK) and tissue distribution studies. • The instrument is integral to the CPL’s role in supporting translational pharmacology, biomarker discovery, and pharmacokinetic/pharmacodynamic (PK/PD) profiling. • Comments to this announcement may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement.